Solid Biosciences’ gene therapy uses a shortened version of the dystrophin protein, which is engineered to mimic the key functions of full-length dystrophin and allows it be delivered more effectively ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...

Guillain-Barré Syndrome is rare but can happen to anyone. Recognizing the first symptoms—tingling, weakness, difficulty ...

Scientists at St. Jude Children’s Research Hospital report results from a promising new approach to treat the rare ...

This is about rearming Britain. Our new defense approach will deliver more jobs, more apprenticeships, and a stronger UK ...

How's your weekend? Have you read about the muscular neutrino? It's so great. This week, we also reported on male stick ...

Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...

The female reproductive system includes internal and external organs, each designed to carry out varying functions. Learn ...

Leveraging the modularity of its FORCE™ platform, Dyne is developing targeted therapeutics that deliver to muscle and the central nervous system (CNS). Dyne has a broad pipeline for neuromuscular ...

Valentine's Day is all about the hearts: heart-shaped chocolates, cards, balloons and even pizza. But the heart hasn't always ...